Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manolopoulos

Showing results (11-20 of 580) with videos related to

Pageof 58
Sort By:
European Journal of Pharmacology|November 24, 2004
Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivoAnna Tavridou, Vangelis G Manolopoulos
Pharmacogenomics|November 23, 2019
Pharmacogenomics of anticoagulation therapy: the last 10 yearsGeorgia Ragia, Vangelis G Manolopoulos
European Journal of Clinical Pharmacology|July 23, 2020
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapiesGeorgia Ragia, Vangelis G Manolopoulos
Pharmacology|October 23, 2004
Atorvastatin and simvastatin decrease the uptake of acetylated low-density lipoprotein by human monocytesAnna Tavridou, Vangelis G Manolopoulos
The Journal of Chemical Physics|January 12, 2010
Zero point energy leakage in condensed phase dynamics: an assessment of quantum simulation methods for liquid waterScott Habershon, David E Manolopoulos
Pharmacogenomics|February 7, 2012
Highlights from the latest articles in diabetes pharmacogenomicsGeorgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|October 26, 2022
The revolution of pharmaco-omics: ready to open new avenues in materializing precision medicine?Georgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|November 27, 2020
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entryGeorgia Ragia, Vangelis G Manolopoulos
Current Medicinal Chemistry|April 9, 2008
Novel molecules targeting dyslipidemia and atherosclerosisA Tavridou, V G Manolopoulos
Expert Opinion on Therapeutic Patents|May 22, 2009
Inhibitors of 5-lipoxygenase activating protein: WO 2008/030369Anna Tavridou, Vangelis G Manolopoulos
Pageof 58

Showing results (11-20 of 580) with videos related to

Sort By:
Pageof 58
European Journal of Pharmacology|November 24, 2004
Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivoAnna Tavridou, Vangelis G Manolopoulos
Pharmacogenomics|November 23, 2019
Pharmacogenomics of anticoagulation therapy: the last 10 yearsGeorgia Ragia, Vangelis G Manolopoulos
European Journal of Clinical Pharmacology|July 23, 2020
Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapiesGeorgia Ragia, Vangelis G Manolopoulos
Pharmacology|October 23, 2004
Atorvastatin and simvastatin decrease the uptake of acetylated low-density lipoprotein by human monocytesAnna Tavridou, Vangelis G Manolopoulos
The Journal of Chemical Physics|January 12, 2010
Zero point energy leakage in condensed phase dynamics: an assessment of quantum simulation methods for liquid waterScott Habershon, David E Manolopoulos
Pharmacogenomics|February 7, 2012
Highlights from the latest articles in diabetes pharmacogenomicsGeorgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|October 26, 2022
The revolution of pharmaco-omics: ready to open new avenues in materializing precision medicine?Georgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|November 27, 2020
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entryGeorgia Ragia, Vangelis G Manolopoulos
Current Medicinal Chemistry|April 9, 2008
Novel molecules targeting dyslipidemia and atherosclerosisA Tavridou, V G Manolopoulos
Expert Opinion on Therapeutic Patents|May 22, 2009
Inhibitors of 5-lipoxygenase activating protein: WO 2008/030369Anna Tavridou, Vangelis G Manolopoulos
Pageof 58